Localization of antigenic sites on the surface glycoprotein of mouse hepatitis virus

References

1. Banner L. R., Keck J. G., Lai M. M. C. 1990; A clustering of RNA recombination sites adjacent to a hypervariable region of the peplomer gene of murine coronavirus. Virology 175:548–555
   [Google Scholar]
2. Barthold S. W., Smith A. L. 1984; Mouse hepatitis virus strain-related patterns of tissue tropism in suckling mice. Archives of Virology 81:103–112
   [Google Scholar]
3. Cavanagh D., Davis P. J., Darbyshire J. H., Peters R. W. 1986; Coronavirus IBV: virus retaining spike glycopolypeptide S2 but not S1 is unable to induce virus-neutralizing or haemagglutination-inhibiting antibody, or induce chicken tracheal protection. Journal of General Virology 67:1435–1442
   [Google Scholar]
4. Collins A. R., Knobler R. L., Powell H., Buchmeier M. J. 1982; Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology 119:371–385
   [Google Scholar]
5. Correa I., Gebauer F., Bullido M. J., Suñé C., Baay M. F. D., Zwaagstra K. A., Posthumus W. P. A., Lenstra J. A., Enjuanes L. 1990; Localization of antigenic sites of the E2 glycoprotein of transmissible gastroenteritis coronavirus. Journal of General Virology 71:271–279
   [Google Scholar]
6. Dalziel R. G., Lampert P. W., Talbot P. J., Buchmeier M. J. 1986; Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence. Journal of Virology 59:463–471
   [Google Scholar]
7. Fleming J. O., Trousdale M. D., El-Zaatari F. A. K., Stohlman S. A., Weiner L. P. 1986; Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. Journal of Virology 58:869–875
   [Google Scholar]
8. Gallagher T. M., Parker S. E., Buchmeier M. J. 1990; Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein. Journal of Virology 64:731–741
   [Google Scholar]
9. Hirano N., Murakami T., Taguchi F., Fujiwara K., Matumoto M. 1981; Comparison of mouse hepatitis virus strains for pathogenicity in weanling mice infected by various routes. Archives of Virology 70:69–73
   [Google Scholar]
10. Kumanishi T. 1967; Brain tumor induced with Rous sarcoma virus, Schmidt-Ruppin strain. I. Induction of brain tumors in adult mice with Rous chicken sarcoma cells. Japanese Journal of Experimental Medicine 37:461–474
    [Google Scholar]
11. Kyuwa S., Stohlman S. A. 1990; Pathogenesis of a neurotropic murine coronavirus, strain JHM in the central nervous system of mice. Seminars in Virology 1:273–280
    [Google Scholar]
12. Parker S. E., Gallagher T. M., Buchmeier M. J. 1989; Sequence analysis reveals extensive polymorphism and evidence of deletions within the E2 glycoprotein gene of several strains of murine hepatitis virus. Virology 173:664–673
    [Google Scholar]
13. Routledge E., Stauber R., Pfleiderer M., Siddell S. G. 1991; Analysis of murine coronavirus surface glycoprotein functions using monoclonal antibodies. Journal of Virology 65:254–264
    [Google Scholar]
14. Siddell S. G. 1982; Coronavirus JHM: tryptic peptide fingerprinting of virion proteins and intracellular polypeptides. Journal of General Virology 62:259–269
    [Google Scholar]
15. Sorensen O., Dugre R., Percy D., Dales S. 1982; In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice. Infection and Immunity 37:1248–1260
    [Google Scholar]
16. Spaan W., Cavanagh D., Horzinek M. C. 1990; Coronaviruses. In Immunochemistry of Viruses II pp. 359–379 Edited by van Regenmortel M. H. V., Neurath A. R. Amsterdam: Elsevier;
    [Google Scholar]
17. van Regenmortel M. H. V. 1990; The structure of viral epitopes. In Immunochemistry of Viruses II pp. 1–24 Edited by van Regenmortel M. H. V., Neurath A. R. Amsterdam: Elsevier;
    [Google Scholar]
18. Vennema H., Heijnen L., Zijderveld A., Horzinek M. C., Spaan W. J. M. 1990; Intracellular transport of recombinant coronavirus spike proteins: implications for virus assembly. Journal of Virology 64:339–346
    [Google Scholar]
19. Wege H., Wege H., Nagashima K., Ter Meulen V. 1979; Structural polypeptides of the murine coronavirus JHM. Journal of General Virology 42:37–47
    [Google Scholar]
20. Wege H., Siddell S. G., Ter Meulen V. 1982; The biology and pathogenesis of coronaviruses. Current Topics in Microbiology and Immunology 99:165–200
    [Google Scholar]
21. Wege H., Dӧrries R., Wege H. 1984; Hybridoma antibodies to the murine coronavirus JHM: characterization of epitopes on the peplomer protein (E2). Journal of General Virology 65:1931–1942
    [Google Scholar]
22. Wege H., Winter J., Meyermann R. 1988; The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis. Journal of General Virology 69:87–98
    [Google Scholar]
23. Weiland E., Mussgay M., Weiland F. 1978; Non producer malignant tumor cells with rescuable sarcoma virus genome isolated from a recurrent Moloney sarcoma. Journal of Experimental Medicine 148:408–423
    [Google Scholar]
24. Weismiller D. G., Sturman L. S., Buchmeier M. J., Fleming J. O., Holmes K. V. 1990; Monoclonal antibodies to the peplomer glycoprotein of coronavirus mouse hepatitis virus identify two subunits and detect a conformational change in the subunit released under mild alkaline conditions. Journal of Virology 64:3051–3055
    [Google Scholar]